Virbac Sa Stock Market Outlook
| VRBCF Stock | USD 346.00 0.00 0.00% |
Roughly 56% of Virbac SA's investor base is looking to short. The analysis of overall sentiment of trading Virbac SA pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Virbac SA's historical and current headlines, can help investors time the market. In addition, many technical investors use Virbac SA stock news signals to limit their universe of possible portfolio assets.
Comfort Level 44
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Virbac SA's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Virbac SA.
News SentimentNeutral | Hype SentimentBearish | Insider SentimentWaiting |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Virbac SA is 'Hold'. Macroaxis provides Virbac SA buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding VRBCF positions.
Execute Virbac SA Advice
The Virbac recommendation should be used to complement the investment advice compiled from the current analysts' consensus on Virbac SA. Macroaxis does not own or have any residual interests in Virbac SA or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Virbac SA's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
For the selected time horizon Virbac SA has a Return On Equity of 0.15, Return On Asset of 0.091, Profit Margin of 0.10 %, Operating Margin of 0.16 %, Current Valuation of 2.1 B and Shares Outstanding of 8.44 MMacroaxis provides recommendation on Virbac SA to complement and cross-verify current analyst consensus on Virbac SA. Our trade recommendation engine determines the firm's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. To make sure Virbac SA is not overpriced, please validate all Virbac SA fundamentals, including its debt to equity, beta, and the relationship between the cash and equivalents and cash flow from operations . Given that Virbac SA has a shares owned by institutions of 25.63 %, we advise you to double-check Virbac SA market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your current risk tolerance and investing horizon.
Virbac SA Trading Alerts and Improvement Suggestions
| Virbac SA generated a negative expected return over the last 90 days | |
| About 50.0% of the company outstanding shares are owned by insiders |
Virbac SA Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Virbac SA or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Virbac SA's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Virbac pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.00 | |
Ir | Information ratio | 0.00 |
Virbac SA Volatility Alert
At this time Virbac SA exhibits very low volatility. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Virbac SA's pink sheet risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Virbac SA's pink sheet price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Virbac SA Fundamentals Vs Peers
Comparing Virbac SA's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Virbac SA's direct or indirect competition across all of the common fundamentals between Virbac SA and the related equities. This way, we can detect undervalued stocks with similar characteristics as Virbac SA or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Virbac SA's fundamental indicators could also be used in its relative valuation, which is a method of valuing Virbac SA by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Virbac SA to competition |
| Fundamentals | Virbac SA | Peer Average |
| Return On Equity | 0.15 | -0.31 |
| Return On Asset | 0.091 | -0.14 |
| Profit Margin | 0.10 % | (1.27) % |
| Operating Margin | 0.16 % | (5.51) % |
| Current Valuation | 2.1 B | 16.62 B |
| Shares Outstanding | 8.44 M | 571.82 M |
| Shares Owned By Insiders | 50.38 % | 10.09 % |
| Shares Owned By Institutions | 25.63 % | 39.21 % |
| Price To Earning | 18.33 X | 28.72 X |
| Price To Book | 4.58 X | 9.51 X |
| Price To Sales | 2.93 X | 11.42 X |
| Revenue | 1.06 B | 9.43 B |
| Gross Profit | 712.85 M | 27.38 B |
| EBITDA | 208.43 M | 3.9 B |
| Net Income | 113.16 M | 570.98 M |
| Cash And Equivalents | 174.57 M | 2.7 B |
| Cash Per Share | 20.67 X | 5.01 X |
| Total Debt | 13.15 M | 5.32 B |
| Debt To Equity | 0.14 % | 48.70 % |
| Current Ratio | 1.68 X | 2.16 X |
| Book Value Per Share | 96.99 X | 1.93 K |
| Cash Flow From Operations | 129.9 M | 971.22 M |
| Earnings Per Share | 13.65 X | 3.12 X |
| Number Of Employees | 5.12 K | 18.84 K |
| Beta | 0.88 | -0.15 |
| Market Capitalization | 3.38 B | 19.03 B |
| Total Asset | 1.2 B | 29.47 B |
| Annual Yield | 0 % | |
| Net Asset | 1.2 B | |
| Last Dividend Paid | 1.25 |
Virbac SA Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Virbac . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Virbac SA Buy or Sell Advice
When is the right time to buy or sell Virbac SA? Buying financial instruments such as Virbac Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Virbac SA in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Drugs Thematic Idea Now
Drugs
Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. The Drugs theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Drugs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Virbac Pink Sheet
Virbac SA financial ratios help investors to determine whether Virbac Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Virbac with respect to the benefits of owning Virbac SA security.